Get Started

PPCB

NASD Propanc Biopharma Inc
Nov 10, 2026 · 6:37 PM ET LAST TRADE Market Closed

$1.74 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.74, $0.03 below the day’s high of $1.77

YTD change
-67.57%
vs 20-day SMA
-31.58%
vs 200-day SMA
-76.21%

Price ranges

Previous day
$1.69 $1.82
open $1.78 close $1.76
-$0.02 (-1.12%)
Today
$1.65 $1.77
open $1.76 now $1.74
-$0.02 (-1.14%)
Past week
$1.63 $1.85
from $1.72 now $1.74
+$0.02 (+1.16%)
Past month
$1.63 $4.61
from $4.40 now $1.74
-$2.66 (-60.45%)
This year
$0.06 $6.79
from $5.37 now $1.74
-$3.63 (-67.57%)

Price & Performance

+1.67 (+1770.35%) / 6M

$-0.1210$0.7923$1.71$2.62May 11Aug 11Nov 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $475,000,000,000.00
  • PPCB is down 68% since the beginning of the year
  • PPCB is down 81% over the past 12 months
  • PPCB is down 60% over the past 1 month

PPCB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +95.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-12.4983
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $15.8M
Beta 3.35

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$50.8K
Debt$1.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.8M

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,411.95 +4.28%
JNJ Johnson & Johnson $282.11 +2.13%
AZN AstraZeneca PLC Sponsored ADR $189.39 +1.59%
ABBV AbbVie, Inc. $293.30 +0.68%
MRK Merck & Co., Inc. $148.76 +1.38%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.